Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Arthritis Research & Therapy|May 6, 2011
Chemerin/ChemR23 pathway: a system beyond chemokinesFlorenzo Iannone, Giovanni LapadulaThe Journal of Rheumatology. Supplement|July 4, 2012
The inhibitor of costimulation of T cells: abataceptFlorenzo Iannone, Giovanni LapadulaAging Clinical and Experimental Research|January 2, 2004
The pathophysiology of osteoarthritisFlorenzo Iannone, Giovanni LapadulaClinical and Experimental Rheumatology|October 20, 2012
Biosimilars in rheumatology: pharmacological and pharmacoeconomic issuesGiovanni Lapadula, Gian Franco FerraccioliBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 2, 2014
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practiceLeonardo Punzi, Giovanni Lapadula, Alessandro MathieuThe Journal of Rheumatology. Supplement|May 3, 2014
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendationsFlorenzo Iannone, Fabrizio Cantini, Giovanni LapadulaClinical Therapeutics|April 19, 2017
Comparing Originator Biologics and Biosimilars: A Review of the Relevant IssuesCorrado Blandizzi, Pier Luigi Meroni, Giovanni LapadulaTherapeutic Drug Monitoring|November 7, 2012
Old and new antirheumatic drugs and the risk of hepatotoxicityMaria Grazia Anelli, Crescenzio Scioscia, Ignazio Grattagliano, et al.HIV Clinical Trials|February 11, 2009
Functional impairments of microcirculation in HIV-positive patients: a laser Doppler fluxometry-based investigationPaolo Maggi, Chiara Bellacosa, Vito Grattagliano, et al.Clinical Rheumatology|November 20, 2015
Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritisFlorenzo Iannone, Giuseppe Lopalco, Luca Cantarini, et al.Pageof 12